|
GENELABS TECH INC, (GNLB) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of novel pharmaceutical products for human health. It is developing, Prestara, an investigational drug for women with systemic lupus erythematosus. The company is also pursuing the discovery of antiviral compounds for treatment of hepatitis C virus infections and is initiating preclinical development work. The company has collaborations with Watson Pharmaceuticals, Inc. and Tanabe Seiyaku Co., Ltd. Genelabs Technologies was incorporated in 1985 and is based in Redwood City, California.
|
GENELABS TECH INC Related |
|
GENELABS.COM Genelabs ... © Genelabs Technologies, Inc. All rights reserved. - Terms of Use ... SEC EDGAR Filings. SEC Section 16 Filings. Corporate Governance ...
|
|
GNLB - Genelabs Technologies Inc Company & Stock Research Report - The company report for Genelabs Technologies Inc - GNLB provides an overview of the company, including a description, quick facts, stock activity summary, stock price...
|
|
Genelabs Technologies, Inc. Company Profile | GNLB Company Information Genelabs Technologies, Inc. Company Profile - View Genelabs Technologies, Inc. (GNLB) Company Information. Financial information, key executives, company news and more.
|
|
